Erythropoietin Promotes Deleterious Cardiovascular Effects and Mortality Risk in a Rat Model of Chronic Sports Doping

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Cardiovascular Toxicology

• Publication date

  2009-10-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12012-009-9054-2PMID 19859831
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The signal transduction mediated by erythropoietin and proinflammatory cytokines in the JAK/STAT pathway in the children with cerebral palsy.

  2009cited by this paper
• Do non-hemopoietic effects of erythropoietin play a beneficial role in heart failure?

  2008cited by this paper
• Erythropoietin and oxidative stress.

  2008cited by this paper
• Erythropoiesis‐stimulating agents and other methods to enhance oxygen transport

  2008cited by this paper
• Erythropoietin: ready for prime-time cardioprotection.

  2008cited by this paper
• Antioxidative effects of erythropoietin.

  2007cited by this paper
• Protective effects of erythropoietin in cardiac ischemia: from bench to bedside.

  2006cited by this paper
• Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients.

  2006cited by this paper
• EPO: renoprotection beyond anemia correction

  2006cited by this paper
• Effect of preventive and regressive isosorbide 5-mononitrate treatment on catecholamine levels in plasma, platelets, adrenals, left ventricle and aorta in cyclosporin A-induced hypertensive rats.

  2005cited by this paper
• Erythropoietin in heart failure and other cardiovascular diseases: hematopoietic and pleiotropic effects.

  2005cited by this paper
• New avenues of exploration for erythropoietin.

  2005cited by this paper
• Influence of prolonged physical exercise on the erythropoietin concentration in blood

  2004cited by this paper
• Erythropoietin as an antiapoptotic, tissue-protective cytokine

  2004cited by this paper
• Recombinant human erythropoietin in sports: a review

  2003cited by this paper
• Eritropoietina humana recombinante no esporte: uma revisao

  2003cited by this paper
• A novel protective effect of erythropoietin in the infarcted heart.

  2003cited by this paper
• Effets cardiovasculaires du dopage

  2001cited by this paper
• Optimización de un método para la determinación de la peroxidación lipídica en suero humano

  2001cited by this paper
• Chronic inborn erythrocytosis leads to cardiac dysfunction and premature death in mice overexpressing erythropoietin.

  2001cited by this paper
• Recombinant erythropoietin in urine.

  2000cited by this paper
• Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans.

  2000cited by this paper
• A global strategy for prevention and detection of blood doping with erythropoietin and related drugs.

  2000cited by this paper
• Biology of erythropoietin.

  1998cited by this paper
• The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay.

  1996influential reference
• Erythropoietin abuse in athletes

  1996influential reference
• Activation of the sympathetic nervous system in hemodialyzed patients treated with erythropoietin.

  1995cited by this paper
• Ergogenic aids.

  1995cited by this paper
• Biology of erythropoietin.

  1994cited by this paper
• Recombinant erythropoietin to improve athletic performance.

  1991cited by this paper
• Serum erythropoietin in cross-country skiers.

  1988cited by this paper
• Serum Erythropoietin in Cross-Country Skiers

  1988cited by this paper

• Effects of erythropoietin on cardiac morphometry in exercised male and female adolescent rats

  2025cites this paper
• Pharmacological and toxicological aspects of doping substances and the role of the sports pharmacist

  2025cites this paper
• Lack of evidence that doping is harmful to the health of elite athletes

  2023cites this paper
• CEPO (carbamylated erythropoietin)-Fc protects hippocampal cells in culture against beta amyloid-induced apoptosis: considering Akt/GSK-3β and ERK signaling pathways

  2020cites this paper
• (Doping, dietary supplements, and cardiovascular system)

  2020cites this paper
• The role of hepcidin in iron metabolism in athletes

  2019cites this paper
• Medicina del deporte

  2019cites this paper
• The Effect of Erythropoietin on Oviductal Congestion during Ischemia Reperfusion Injury in Rats

  2017cites this paper
• The Effect of Erythropoietin on Oviductal Congestion during Ischemia Reperfusion Injury in Rats

  2017cites this paper
• The Erythropoietin Effect on Uterus Congestion after Uterine Ischemia Reperfusion

  2017cites this paper
• Safety profile of solid lipid nanoparticles loaded with rosmarinic acid for oral use: in vitro and animal approaches

  2016cites this paper
• Chronic preclinical safety evaluation of EPO-018B, a pegylated peptidic erythropoiesis-stimulating agent in monkeys and rats.

  2016cites this paper
• Impaired renal endothelial nitric oxide synthase and reticulocyte production as modulators of hypertension induced by rHuEPO in the rat.

  2016cites this paper
• Doping und Medikamentenmissbrauch

  2015cites this paper
• Hepcidin and sports anemia

  2014cites this paper
• Transition from Cyclosporine-Induced Renal Dysfunction to Nephrotoxicity in an in Vivo Rat Model

  2014cites this paper
• Influencia de administración de eritropoyetina humana recombinante en el rendimiento físico: un estudio de revisión

  2014cites this paper
• Use of Aspirin in normalization of recombinant human erythropoietin-mediated hyper-reactivity of platelets in rats

  2014cites this paper
• Mort subite au cours des activités physiques et sportives. Recommandations pour des mesures préventives

  2013cites this paper
• The neuroprotective and neurorescue effects of carbamylated erythropoietin Fc fusion protein (CEPO-Fc) in a rat model of Parkinson's disease.

  2013cites this paper
• Cardiovascular Adverse Effects of Doping in

  2012cites this paper
• Cardiovascular adverse effects of doping in sports.

  2012cites this paper
• Rapid detection of erythropoiesis-stimulating agents in urine and serum.

  2012cites this paper
• Chemopreventive Efficacy of Atorvastatin against Nitrosamine-Induced Rat Bladder Cancer: Antioxidant, Anti-Proliferative and Anti-Inflammatory Properties

  2012cites this paper
• Exercise, Science and Designer Doping: Traditional and Emerging Trends.

  2012cites this paper
• L’hypertension artérielle et les désordres vasculaires induits par l'érythropoïétine recombinante humaine et le système rénine-angiotensine-aldostérone : Effet de l’exercice et des cellules T régulatrices

  2011cites this paper
• Polyglobulie

  2010cites this paper
• Recombinant human erythropoietin treatment protects the cardio-renal axis in a model of moderate chronic renal failure

  2010cites this paper
• O R I G I N a L I N V E S T I G a T I O N Open Access

  year unknowncites this paper